Diamonds and Dogs


General Electric (GE) spinning off more businesses. GE is up 8% to a four month high after agreeing to sell their biopharma business to Danaher for $21.4 billion. Even though some thought the biopharma business was the "crown jewel" for GE's healthcare unit, shareholders are happy today. This move is a big step toward GE's goal of deleveraging its $121 billion debt load by selling part of its fast-growing life sciences division. GE's bonds are reacting well to this move. GE was expected to IPO their health care businesses this Spring, but that deal is on hold. Danaher (DHR) is also up 8% as one analyst called the acquisition a "multi-year home run."

McDermott (MDT) one of the few stocks trading lower today. The engineering and construction company is down 5% not far from a 52 week range following disappointing earnings. The company missed on earnings and sales due to significant non-recurring charges, including those related to goodwill and deferred tax assets. The company expects the first quarter will likely to be the softest quarter of the year and that operating performance in the second half of 2019 is likely to be stronger than the first half. The company did reiterate guidance for the full year.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.